It would be interesting to explore whether MYC/BCL6-DH DLBCL also result from high-grade transformation of a low-grade lesion such as follicular or marginal zone B-cell lymphoma or their precursor lesions, and their heterogeneous molecular subtypes reflect their inherent features from their derived low-grade lesion. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.